Kitov Pharmaceuticals Holdings Ltd (NASDAQ:KTOV) fell 1.4% during trading on Monday . The company traded as low as $2.85 and last traded at $2.87, with a volume of 104,800 shares changing hands. The stock had previously closed at $2.91.

A number of brokerages have commented on KTOV. Rodman & Renshaw reissued a “buy” rating on shares of Kitov Pharmaceuticals Holdings in a research note on Saturday, May 14th. Zacks Investment Research raised Kitov Pharmaceuticals Holdings from a “hold” rating to a “buy” rating and set a $3.25 price objective for the company in a research note on Wednesday, July 13th.

The company’s market cap is $19.50 million. The stock’s 50-day moving average is $3.07 and its 200 day moving average is $4.02.

Kitov Pharmaceuticals Holdings Ltd is an Israel-based company that develops non-steroidal anti-inflammatory drugs that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.